Annual EBITDA
$1.16 M
+$81.73 M+101.44%
31 December 2023
Summary:
Molecular Templates annual earnings before interest, taxes, depreciation & amortization is currently $1.16 million, with the most recent change of +$81.73 million (+101.44%) on 31 December 2023. During the last 3 years, it has risen by +$100.45 million (+101.17%). MTEM annual EBITDA is now -95.83% below its all-time high of $27.93 million, reached on 31 December 2015.MTEM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$7.01 M
-$8.74 M-506.55%
30 June 2024
Summary:
Molecular Templates quarterly earnings before interest, taxes, depreciation & amortization is currently -$7.01 million, with the most recent change of -$8.74 million (-506.55%) on 30 June 2024. Over the past year, it has dropped by -$4.40 million (-168.18%). MTEM quarterly EBITDA is now -113.36% below its all-time high of $52.51 million, reached on 31 December 2015.MTEM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$10.63 M
+$654.00 K+5.80%
30 June 2024
Summary:
Molecular Templates TTM earnings before interest, taxes, depreciation & amortization is currently -$10.63 million, with the most recent change of +$654.00 thousand (+5.80%) on 30 June 2024. Over the past year, it has increased by +$4.34 million (+29.01%). MTEM TTM EBITDA is now -131.73% below its all-time high of $33.48 million, reached on 30 September 2016.MTEM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MTEM EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +101.4% | -168.2% | +29.0% |
| 3 y3 years | +101.2% | +74.7% | +88.5% |
| 5 y5 years | +104.1% | +81.3% | +81.6% |
MTEM EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +101.2% | -149.5% | +74.7% | -1012.8% | +88.5% |
| 5 y | 5 years | at high | +101.2% | -149.5% | +81.3% | -1012.8% | +89.8% |
| alltime | all time | -95.8% | +101.2% | -113.4% | +81.3% | -131.7% | +89.8% |
Molecular Templates EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$7.01 M(-506.6%) | -$10.63 M(-5.8%) |
| Mar 2024 | - | $1.73 M(-163.4%) | -$11.28 M(-1069.0%) |
| Dec 2023 | $1.16 M(-101.4%) | -$2.72 M(+4.1%) | $1.16 M(-107.8%) |
| Sept 2023 | - | -$2.62 M(-65.9%) | -$14.97 M(-55.9%) |
| June 2023 | - | -$7.67 M(-154.1%) | -$33.92 M(-28.9%) |
| Mar 2023 | - | $14.17 M(-175.2%) | -$47.71 M(-40.8%) |
| Dec 2022 | -$80.57 M(+10.3%) | -$18.85 M(-12.6%) | -$80.56 M(+16.6%) |
| Sept 2022 | - | -$21.57 M(+0.6%) | -$69.09 M(-8.1%) |
| June 2022 | - | -$21.45 M(+14.8%) | -$75.17 M(+12.3%) |
| Mar 2022 | - | -$18.69 M(+153.5%) | -$66.93 M(-8.3%) |
| Dec 2021 | -$73.01 M(-26.5%) | -$7.37 M(-73.3%) | -$73.01 M(-20.8%) |
| Sept 2021 | - | -$27.66 M(+109.4%) | -$92.22 M(+7.2%) |
| June 2021 | - | -$13.21 M(-46.7%) | -$86.05 M(-16.5%) |
| Mar 2021 | - | -$24.77 M(-6.8%) | -$103.01 M(+3.7%) |
| Dec 2020 | -$99.29 M(+48.3%) | -$26.58 M(+23.6%) | -$99.29 M(+13.2%) |
| Sept 2020 | - | -$21.50 M(-28.7%) | -$87.69 M(-15.5%) |
| June 2020 | - | -$30.17 M(+43.3%) | -$103.73 M(+26.1%) |
| Mar 2020 | - | -$21.05 M(+40.5%) | -$82.29 M(+22.9%) |
| Dec 2019 | -$66.94 M(+136.3%) | -$14.98 M(-60.1%) | -$66.94 M(+15.7%) |
| Sept 2019 | - | -$37.54 M(+330.1%) | -$57.88 M(+132.2%) |
| June 2019 | - | -$8.73 M(+53.2%) | -$24.92 M(-2.9%) |
| Mar 2019 | - | -$5.70 M(-3.6%) | -$25.67 M(-9.4%) |
| Dec 2018 | -$28.32 M(+28.0%) | -$5.91 M(+29.0%) | -$28.32 M(-2.8%) |
| Sept 2018 | - | -$4.58 M(-51.7%) | -$29.14 M(-17.6%) |
| June 2018 | - | -$9.48 M(+13.6%) | -$35.37 M(+37.7%) |
| Mar 2018 | - | -$8.35 M(+24.0%) | -$25.69 M(+18.1%) |
| Dec 2017 | -$22.13 M(-7.5%) | -$6.73 M(-37.8%) | -$21.76 M(+9.1%) |
| Sept 2017 | - | -$10.81 M(-5561.6%) | -$19.95 M(+39.5%) |
| June 2017 | - | $198.00 K(-104.5%) | -$14.30 M(-29.5%) |
| Mar 2017 | - | -$4.42 M(-10.2%) | -$20.29 M(-15.3%) |
| Dec 2016 | -$23.94 M(-185.7%) | -$4.92 M(-4.8%) | -$23.94 M(-171.5%) |
| Sept 2016 | - | -$5.16 M(-10.8%) | $33.48 M(+4.2%) |
| June 2016 | - | -$5.79 M(-28.3%) | $32.13 M(+9.9%) |
| Mar 2016 | - | -$8.07 M(-115.4%) | $29.24 M(+4.7%) |
| Dec 2015 | $27.93 M(-193.3%) | $52.51 M(-904.9%) | $27.93 M(-187.7%) |
| Sept 2015 | - | -$6.52 M(-24.8%) | -$31.85 M(-2.5%) |
| June 2015 | - | -$8.68 M(-7.5%) | -$32.65 M(+5.0%) |
| Mar 2015 | - | -$9.38 M(+28.9%) | -$31.10 M(+3.9%) |
| Dec 2014 | -$29.94 M | -$7.28 M(-0.7%) | -$29.94 M(-0.3%) |
| Sept 2014 | - | -$7.33 M(+2.8%) | -$30.03 M(+9.2%) |
| June 2014 | - | -$7.13 M(-13.3%) | -$27.49 M(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$8.22 M(+11.6%) | -$26.99 M(+10.1%) |
| Dec 2013 | -$24.52 M(+29.1%) | -$7.36 M(+53.7%) | -$24.52 M(+7.5%) |
| Sept 2013 | - | -$4.79 M(-27.7%) | -$22.81 M(+5.3%) |
| June 2013 | - | -$6.62 M(+15.2%) | -$21.66 M(+23.0%) |
| Mar 2013 | - | -$5.75 M(+1.6%) | -$17.62 M(-7.2%) |
| Dec 2012 | -$18.99 M(-35.6%) | -$5.65 M(+55.0%) | -$18.99 M(-10.9%) |
| Sept 2012 | - | -$3.65 M(+41.8%) | -$21.31 M(-15.8%) |
| June 2012 | - | -$2.57 M(-63.9%) | -$25.30 M(-13.7%) |
| Mar 2012 | - | -$7.12 M(-10.7%) | -$29.32 M(-0.6%) |
| Dec 2011 | -$29.51 M(+26.1%) | -$7.97 M(+4.3%) | -$29.51 M(+7.1%) |
| Sept 2011 | - | -$7.64 M(+15.8%) | -$27.55 M(+6.6%) |
| June 2011 | - | -$6.60 M(-9.7%) | -$25.85 M(+3.0%) |
| Mar 2011 | - | -$7.31 M(+21.5%) | -$25.11 M(+7.3%) |
| Dec 2010 | -$23.40 M(+12.9%) | -$6.01 M(+1.3%) | -$23.40 M(+2.6%) |
| Sept 2010 | - | -$5.94 M(+1.5%) | -$22.80 M(+4.0%) |
| June 2010 | - | -$5.85 M(+4.5%) | -$21.92 M(+2.7%) |
| Mar 2010 | - | -$5.60 M(+3.4%) | -$21.34 M(+2.9%) |
| Dec 2009 | -$20.73 M(+16.5%) | -$5.41 M(+7.1%) | -$20.73 M(+3.8%) |
| Sept 2009 | - | -$5.05 M(-4.0%) | -$19.98 M(+3.3%) |
| June 2009 | - | -$5.27 M(+5.5%) | -$19.34 M(+97.9%) |
| Mar 2009 | - | -$4.99 M(+7.0%) | -$9.78 M(+0.9%) |
| Dec 2008 | -$17.80 M(-43.2%) | -$4.66 M(+5.5%) | -$9.69 M(-22.2%) |
| Sept 2008 | - | -$4.42 M(-202.8%) | -$12.45 M(-15.6%) |
| June 2008 | - | $4.30 M(-187.6%) | -$14.75 M(+38.1%) |
| Mar 2008 | - | -$4.91 M(-33.9%) | -$10.68 M(-29.4%) |
| Dec 2007 | -$31.31 M(-46.3%) | -$7.42 M(+10.5%) | -$15.12 M(-14.8%) |
| Sept 2007 | - | -$6.72 M(-180.3%) | -$17.75 M(-37.2%) |
| June 2007 | - | $8.37 M(-189.5%) | -$28.26 M(-46.6%) |
| Mar 2007 | - | -$9.35 M(-7.0%) | -$52.94 M(-9.2%) |
| Dec 2006 | -$58.32 M(+26.9%) | -$10.05 M(-41.6%) | -$58.32 M(-9.2%) |
| Sept 2006 | - | -$17.23 M(+5.6%) | -$64.23 M(+9.1%) |
| June 2006 | - | -$16.32 M(+10.8%) | -$58.85 M(+11.0%) |
| Mar 2006 | - | -$14.73 M(-7.7%) | -$53.02 M(+15.4%) |
| Dec 2005 | -$45.96 M(-290.7%) | -$15.96 M(+34.8%) | -$45.96 M(-560.8%) |
| Sept 2005 | - | -$11.85 M(+13.0%) | $9.97 M(-33.8%) |
| June 2005 | - | -$10.49 M(+36.7%) | $15.06 M(-41.0%) |
| Mar 2005 | - | -$7.67 M(-119.2%) | $25.55 M(-23.1%) |
| Dec 2004 | $24.10 M(-394.4%) | $39.98 M(-691.2%) | $33.21 M(-591.2%) |
| Sept 2004 | - | -$6.76 M | -$6.76 M |
| Dec 2003 | -$8.19 M(+230.8%) | - | - |
| Dec 2002 | -$2.47 M | - | - |
FAQ
- What is Molecular Templates annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Molecular Templates?
- What is Molecular Templates annual EBITDA year-on-year change?
- What is Molecular Templates quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Molecular Templates?
- What is Molecular Templates quarterly EBITDA year-on-year change?
- What is Molecular Templates TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Molecular Templates?
- What is Molecular Templates TTM EBITDA year-on-year change?
What is Molecular Templates annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of MTEM is $1.16 M
What is the all time high annual EBITDA for Molecular Templates?
Molecular Templates all-time high annual earnings before interest, taxes, depreciation & amortization is $27.93 M
What is Molecular Templates annual EBITDA year-on-year change?
Over the past year, MTEM annual earnings before interest, taxes, depreciation & amortization has changed by +$81.73 M (+101.44%)
What is Molecular Templates quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of MTEM is -$7.01 M
What is the all time high quarterly EBITDA for Molecular Templates?
Molecular Templates all-time high quarterly earnings before interest, taxes, depreciation & amortization is $52.51 M
What is Molecular Templates quarterly EBITDA year-on-year change?
Over the past year, MTEM quarterly earnings before interest, taxes, depreciation & amortization has changed by -$4.40 M (-168.18%)
What is Molecular Templates TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of MTEM is -$10.63 M
What is the all time high TTM EBITDA for Molecular Templates?
Molecular Templates all-time high TTM earnings before interest, taxes, depreciation & amortization is $33.48 M
What is Molecular Templates TTM EBITDA year-on-year change?
Over the past year, MTEM TTM earnings before interest, taxes, depreciation & amortization has changed by +$4.34 M (+29.01%)